Sabahat Yasmeen Sheikh, Firoj Hassan, Deepanjali Shukla, Shashi Bala, Tabrez Faruqui, Yusuf Akhter, Abdul Rahman Khan, Malik Nasibullah
Leishmania, a protozoan parasite, is responsible for the occurrence of leishmaniasis, a disease that is prevalent in tropical regions. Visceral Leishmaniasis (VL), also known as kala-azar in Asian countries, is one of the most significant forms of VL, along with Cutaneous Leishmaniasis (CL) and Mucocutaneous Leishmaniasis (ML). Management of this condition typically entails the use of chemotherapy as the sole therapeutic option. The current treatments for leishmaniasis present several drawbacks, including a multitude of side effects, prolonged treatment duration, disparate efficacy across different regions, and the emergence of resistance...
January 23, 2024: Parasitology International